FFCP PHASE1:Hg19::chr6:68597240..68597258,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=NA | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=no_gencodeV16_or_build2_transcript | |||
|HGNC=NA | |||
|TSSclassifier=strong | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr6:68597240..68597258,- | |||
|coexpression_cluster_id=C93 | |||
|description=CAGE_peak_at_chr6:68597240..68597258,- | |||
|id=chr6:68597240..68597258,- | |||
|ontology_enrichment_celltype=CL:0000763!1.04e-20!112;CL:0000049!1.04e-20!112;CL:0002032!3.31e-13!165;CL:0000837!3.31e-13!165;CL:0000037!1.47e-12!172;CL:0000566!1.47e-12!172;CL:0000988!1.02e-11!182 | |||
|ontology_enrichment_celltype_v019=CL:0000763;1.17e-11;100!CL:0000054;7.49e-09;2!CL:0000137;7.49e-09;2!CL:0000092;7.49e-09;2 | |||
|ontology_enrichment_celltype_v019_2=CL:0000763,1.37e-22,108;CL:0000049,1.37e-22,108;CL:0002032,7.41e-15,161;CL:0000837,7.41e-15,161;CL:0000037,3.40e-14,168;CL:0000988,2.02e-13,177;CL:0000054,6.42e-09,2;CL:0000137,6.42e-09,2;CL:0000092,6.42e-09,2 | |||
|ontology_enrichment_development_v019=CL:0000049;6.37e-10;108 | |||
|ontology_enrichment_disease=DOID:8692!7.64e-73!31;DOID:1240!2.06e-57!39;DOID:1036!1.72e-55!8;DOID:2531!4.05e-49!51;DOID:0060083!4.05e-49!51;DOID:0050686!1.97e-23!137;DOID:162!1.98e-12!235;DOID:14566!4.17e-12!239;DOID:0060085!1.43e-10!1;DOID:3165!1.43e-10!1;DOID:0060121!1.43e-10!1;DOID:2438!1.43e-10!1;DOID:4418!1.43e-10!1 | |||
|ontology_enrichment_disease_v019=DOID:1036;6.53e-92;8!DOID:8692;2.77e-67;31!DOID:1240;3.33e-45;39!DOID:2531;4.93e-31;51!DOID:0060083;4.93e-31;51!DOID:0060085;2.25e-16;1!DOID:3165;2.25e-16;1!DOID:0060121;2.25e-16;1!DOID:2438;2.25e-16;1!DOID:4418;2.25e-16;1!DOID:200;7.49e-09;2!DOID:4305;7.49e-09;2 | |||
|ontology_enrichment_disease_v019_2=DOID:1036,9.18e-92,8;DOID:8692,1.74e-69,31;DOID:1240,4.39e-55,39;DOID:2531,2.65e-49,51;DOID:0060083,2.65e-49,51;DOID:0050686,1.26e-17,137;DOID:0060085,1.65e-16,1;DOID:3165,1.65e-16,1;DOID:0060121,1.65e-16,1;DOID:2438,1.65e-16,1;DOID:4418,1.65e-16,1;DOID:162,7.82e-10,235;DOID:14566,1.33e-09,239;DOID:200,6.42e-09,2;DOID:4305,6.42e-09,2 | |||
|ontology_enrichment_uberon= | |||
|ontology_enrichment_uberon_v019= | |||
|ontology_enrichment_uberon_v019_2= | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0654895377488563,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.215915916102139,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.59873811429845,0,0,6.16781686521655,0,0.228234679033192,0,0,0,1.2847046008296,0,0,0,4.91585222893533,6.03925491309523,6.84081481018825,0.976940477010201,0.835218521685727,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.291604613383254,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.09886179476517,0,4.96310453357798,4.70550082362575,5.37029078322697,4.74384331810463,1.27149263184303,0,0.163232808159148,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.78843150532691,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.64185041498678,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.280272163313789,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr6:68597240..68597258,- | |||
}} |
Latest revision as of 02:47, 31 July 2015
Short description: | p@chr6:68597240..68597258, - |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_at_chr6:68597240..68597258, - |
Coexpression cluster: | C93_chronic_acute_leukemia_acantholytic_medulloblastoma_testis_papillotubular |
Association with transcript: | NA |
EntrezGene: | NA |
HGNC: | NA |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
myeloid cell | 1.37e-22 | 108 |
common myeloid progenitor | 1.37e-22 | 108 |
hematopoietic oligopotent progenitor cell | 7.41e-15 | 161 |
hematopoietic multipotent progenitor cell | 7.41e-15 | 161 |
hematopoietic stem cell | 3.40e-14 | 168 |
hematopoietic cell | 2.02e-13 | 177 |
bone matrix secreting cell | 6.42e-09 | 2 |
osteocyte | 6.42e-09 | 2 |
osteoclast | 6.42e-09 | 2 |
Ontology term | p-value | n |
---|---|---|
chronic leukemia | 9.18e-92 | 8 |
myeloid leukemia | 1.74e-69 | 31 |
leukemia | 4.39e-55 | 39 |
hematologic cancer | 2.65e-49 | 51 |
immune system cancer | 2.65e-49 | 51 |
organ system cancer | 1.26e-17 | 137 |
organ system benign neoplasm | 1.65e-16 | 1 |
skin benign neoplasm | 1.65e-16 | 1 |
integumentary system benign neoplasm | 1.65e-16 | 1 |
dermis tumor | 1.65e-16 | 1 |
cutaneous fibrous histiocytoma | 1.65e-16 | 1 |
cancer | 7.82e-10 | 235 |
disease of cellular proliferation | 1.33e-09 | 239 |
giant cell tumor | 6.42e-09 | 2 |
bone giant cell tumor | 6.42e-09 | 2 |